Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.8110
+0.0510 (6.71%)
Apr 2, 2025, 4:00 PM EDT - Market closed

Estrella Immunopharma Balance Sheet

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
0.924.172.484.09-
Cash & Short-Term Investments
0.924.172.484.09-
Cash Growth
-89.86%68.02%-39.36%--
Receivables
--0.27--
Prepaid Expenses
0.720.29-0.83-
Total Current Assets
1.644.452.754.92-
Long-Term Deferred Charges
--0.28--
Total Assets
3.144.453.034.92-
Accrued Expenses
2.790.148.850.03-
Current Portion of Leases
-00.02--
Current Income Taxes Payable
00.04---
Other Current Liabilities
0.200.880.92-
Total Current Liabilities
30.189.760.95-
Other Long-Term Liabilities
--0.010.01-
Total Liabilities
30.189.770.96-
Common Stock
0000-
Additional Paid-In Capital
24.6424.120.450.03-
Retained Earnings
-23.93-19.5-12.19-1.07-
Treasury Stock
-0.57-0.35---
Total Common Equity
0.144.27-11.74-1.04-
Shareholders' Equity
0.144.27-6.743.96-
Total Liabilities & Equity
3.144.453.034.92-
Total Debt
-00.02--
Net Cash (Debt)
0.924.162.464.09-
Net Cash Growth
-89.86%69.36%-39.90%--
Net Cash Per Share
0.030.158.04--
Filing Date Shares Outstanding
36.1736.1935.20.18-
Total Common Shares Outstanding
36.1936.294.060.18-
Working Capital
-1.364.27-7.013.97-
Book Value Per Share
0.000.12-2.89-5.91-
Tangible Book Value
0.144.27-11.74-1.04-
Tangible Book Value Per Share
0.000.12-2.89-5.91-
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q